Chronic Kidney Disease-Induced Cardiac Fibrosis Is Ameliorated by Reducing Circulating Levels of a Non-Dialysable Uremic Toxin, Indoxyl Sulfate

Long-Term Effects of the Oral Adsorbent, AST-120, in Patients with Chronic Renal Failure

(2013) K Maeda et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Effects of AST-120 on Left Ventricular Mass in Predialysis Patients

(2011) Kentaro Nakai et al.   AMERICAN JOURNAL OF NEPHROLOGY

NF-κB plays an important role in indoxyl sulfate-induced cellular senescence, fibrotic gene expression, and inhibition of proliferation in proximal tubular cells

(2011) Hidehisa Shimizu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes?

(2010) S. Lekawanvijit et al.   EUROPEAN HEART JOURNAL

Differences in Myocardial Structure and Coronary Microvasculature Between Men and Women With Coronary Artery Disease

(2010) Duncan J. Campbell et al.   HYPERTENSION

Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry

(2010) Kaori Kikuchi et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Inflammation, kidney function and albuminuria in the Framingham Offspring cohort

(2010) Ashish Upadhyay et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Chronic urotensin II receptor antagonist treatment does not alter hypertrophy or fibrosis in a rat model of pressure-overload hypertrophy

(2010) Andrew R. Kompa et al.   PEPTIDES

Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats

(2009) Lavinia Tran et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Left Ventricular Mass in Chronic Kidney Disease and ESRD

(2009) R. J. Glassock et al.   Clinical Journal of the American Society of Nephrology

Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease Patients

(2009) F. C. Barreto et al.   Clinical Journal of the American Society of Nephrology

Do all protein bound renal toxins exert physiological effects on cardiac cells?

(2009) P. Iyngkaran et al.   Heart Lung and Circulation

Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites

(2009) W. R. Wikoff et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction

(2008) Arintaya Phrommintikul et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Long-Term but Not Short-Term p38 Mitogen-Activated Protein Kinase Inhibition Improves Cardiac Function and Reduces Cardiac Remodeling Post-Myocardial Infarction

(2008) A. R. Kompa et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

AST-120 Treatment in Pre-Dialysis Period Affects the Prognosis in Patients on Hemodialysis

(2008) Haruhiko Ueda et al.   RENAL FAILURE

NON-CORONARY HEART DISEASE IN DIALYSIS PATIENTS: Hypertrophy and Fibrosis in the Cardiomyopathy of Uremia-Beyond Coronary Heart Disease

(2008) Marie-Luise Gross et al.   SEMINARS IN DIALYSIS